טוען...
Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis
Liver fibrosis is caused by excessive accumulation of extracellular matrix during chronic liver injuries. Although clinical evidence suggests that liver fibrosis can be reversed, there is no standard therapy for liver fibrosis. Moreover, there is a lack of diagnostic tools to detect early-stage live...
שמור ב:
| הוצא לאור ב: | J Pharmacol Exp Ther |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The American Society for Pharmacology and Experimental Therapeutics
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6806344/ https://ncbi.nlm.nih.gov/pubmed/30886124 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.118.256156 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|